Mill Creek Capital Advisors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$55.6M Sell
227,635
-10,461
-4% -$2.44M 1.14% 16
2025
Q4
$49.3M Sell
238,096
-1,032
-0.4% -$204K 1% 17
2025
Q3
$44.3M Sell
239,128
-21
-0% -$3.6K 0.91% 17
2025
Q2
$36.5M Buy
239,149
+957
+0.4% +$147K 0.81% 17
2025
Q1
$39.5M Sell
238,192
-10,469
-4% -$1.64M 0.96% 16
2024
Q4
$36M Buy
248,661
+1,144
+0.5% +$177K 0.86% 18
2024
Q3
$40.1M Sell
247,517
-7,631
-3% -$1.22M 0.97% 18
2024
Q2
$37.3M Sell
255,148
-8,225
-3% -$1.22M 0.95% 18
2024
Q1
$41.7M Buy
263,373
+6,561
+3% +$1.04M 1.13% 16
2023
Q4
$40.3M Sell
256,812
-759
-0.3% -$116K 1.19% 16
2023
Q3
$40.1M Sell
257,571
-18,592
-7% -$3.07M 1.33% 15
2023
Q2
$45.7M Sell
276,163
-12,999
-4% -$2.1M 1.48% 14
2023
Q1
$44.8M Sell
289,162
-757
-0.3% -$122K 1.65% 13
2022
Q4
$51.2M Buy
+289,919
New +$50.1M 2.13% 7

Other funds holding JNJ

Mill Creek Capital Advisors's JNJ Position: Q1 2026 in Review

Mill Creek Capital Advisors reduced its Johnson & Johnson (JNJ) stake by 4.4% in Q1 2026, selling an estimated $2.44M and leaving 227,635 shares worth $55.6M. The position accounts for 1.14% of the portfolio, ranked #16.

Mill Creek Capital Advisors first reported a position in JNJ in Q4 2022 and has held it in 14 quarters since. 4,615 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Mill Creek Capital Advisors held 227,635 shares of Johnson & Johnson worth $55.6M as of Q1 2026.
  • Mill Creek Capital Advisors sold 10,461 Johnson & Johnson shares in Q1 2026, an estimated $2.44M.
  • Johnson & Johnson made up 1.14% of Mill Creek Capital Advisors's portfolio in Q1 2026, its #16 holding.
  • Mill Creek Capital Advisors first reported a position in Johnson & Johnson in Q4 2022 and has held it in 14 quarters since.
  • 4,615 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Mill Creek Capital Advisors's 13F filing for Q1 2026, filed 14 May 2026.